| 1. |
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006). Overweight, obesity,
and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778
|
| |
| 2. |
Sharma AM (2003) Obesity and cardiovascular risk. Growth Horm IGF Res 13(Suppl A): S10–S17
|
| |
| 3. |
Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643
|
| |
| 4. |
National Heart Lung and Blood institute and National Institutes of Health (1998). Clinical guidelines on the identification,
evaluation and treatment of overweight and obesity in adults. The Evidence Report
|
| |
| 5. |
Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab; 89:2583–2589
|
| |
| 6. |
Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. (2006) Body-mass index and symptoms of gastroesophageal reflux
in women. N Engl J Med 354:2340–2348
|
| |
| 7. |
Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys
in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28(Suppl 4):S58–S65
|
| |
| 8. |
Juge-Aubry CE, Henrichot E, Meier CA (2005) Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab
19:547–566
|
| |
| 9. |
Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552–2563
|
| |
| 10. |
Banerjee RR, Lazar MA (2003) Resistin: molecular history and prognosis. J Mol Med 81:218–226
|
| |
| 11. |
Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe
E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y,
Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430
|
| |
| 12. |
Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U
S A 100:7265–7270
|
| |
| 13. |
Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD (2001) Chemokines control fat accumulation and leptin secretion
by cultured human adipocytes. Mol Cell Endocrinol 175:81–92
|
| |
| 14. |
Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA (2005) Production of chemokines
by perivascular adipose tissue: a role in the patho-genesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25:2594–2599
|
| |
| 15. |
Dietze D, Koenen M, Rohrig K, Horikoshi H, Hauner H, Eckel J (2002) Impairment of insulin signaling in human skeletal muscle
cells by co-culture with human adipocytes. Diabetes 51:2369–2376
|
| |
| 16. |
Suganami T, Nishida J, Ogawa Y (2005) A paracrine loop between adipocytes and macro-phages aggravates inflammatory changes:
role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25:2062–2068
|
| |
| 17. |
Sell H, Dietze-Schroeder D, Kaiser U, Eckel J (2006) Monocyte chemotactic protein-1 is a potential player in the negative
cross-talk between adipose tissue and skeletal muscle. Endocrinology 147:2458–2467
|
| |
| 18. |
Wang Z, Lv J, Zhang R, Zhu Y, Zhu D, Sun Y, Zhu J, Han X (2006) Co-culture with fat cells induces cellular insulin resistance
in primary hepatocytes. Biochem Biophys Res Commun 345:976–983
|
| |
Loading...